(Q40844297)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1

Elisavet Serti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

8

Barbara Rehermann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

2

Heiyoung Park

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Meghan Keane

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ashley C O'Keefe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Elenita Rivera

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

T Jake Liang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Marc Ghany

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

4 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

724-735

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.

4 March 2020

cites work

1 reference

12 December 2020

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

1 reference

12 December 2020

Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection

1 reference

12 December 2020

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

1 reference

12 December 2020

Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation

1 reference

12 December 2020

Dissecting CD56dim human NK cells

1 reference

12 December 2020

Innate and adaptive immune responses in HCV infections

1 reference

12 December 2020

Emergent properties of the interferon-signalling network may underlie the success of hepatitis C treatment

1 reference

12 December 2020

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

12 December 2020

Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons

1 reference

12 December 2020

Current and future therapies for hepatitis C virus infection

1 reference

12 December 2020

Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.

1 reference

12 December 2020

Natural killer cells suppress full cycle HCV infection of human hepatocytes

1 reference

12 December 2020

Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options

1 reference

12 December 2020

Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A

1 reference

12 December 2020

Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes

1 reference

12 December 2020

Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin.

1 reference

12 December 2020

A SPECIAL MEETING REVIEW EDITION: Advances in the Treatment of Hepatitis C Virus Infection From EASL 2015: The 50th Annual Meeting of the European Association for the Study of the Liver • April 22-26, 2015 • Vienna, AustriaSpecial Reporting on:• Dac

1 reference

12 December 2020

Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders

1 reference

12 December 2020

Preliminary study of two antiviral agents for hepatitis C genotype 1.

1 reference

12 December 2020

Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function

1 reference

12 December 2020

Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication.

1 reference

12 December 2020

Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells

1 reference

12 December 2020

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

1 reference

12 December 2020

Interferon signaling and treatment outcome in chronic hepatitis C

1 reference

12 December 2020

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders

1 reference

12 December 2020

Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment

1 reference

12 December 2020

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

1 reference

12 December 2020

Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo

1 reference

12 December 2020

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.

1 reference

12 December 2020

Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment

1 reference

12 December 2020

Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C

1 reference

12 December 2020

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies

1 reference

12 December 2020

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

12 December 2020

Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes

1 reference

12 December 2020

Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection

1 reference

12 December 2020

10.1136/GUTJNL-2015-310033

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

PubMed publication ID

26733671

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26733671%20AND%20SRC:MED&resulttype=core&format=json